Abbott's Plate Is Full With the Integration of St. Jude; Our FVE Remains Steady
Abbott Labs reported first-quarter results that were largely consistent with our expectations, and we’re holding steady on our fair value estimate. In this first quarter that incorporates the addition of St. Jude Medical, Abbott saw quarterly revenue rise on a comparable basis by 3.2%, fueled by U.S. diagnostics, established pharmaceuticals, and the beefed-up medical device segment. Our view of Abbott’s narrow economic moat remains unchanged. Nonetheless, we think the process of integrating St. ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.